These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 20077433

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Inhibitory effect of bcl-2 antisense oligodeoxynucleotides on growth of human lung carcinoma xenograft in nude mice].
    He DM, Zhang H.
    Ai Zheng; 2006 Jan; 25(1):40-4. PubMed ID: 16405747
    [Abstract] [Full Text] [Related]

  • 4. Increased anti-tumour efficacy of doxorubicin when combined with sulindac in a xenograft model of an MRP-1-positive human lung cancer.
    O'Connor R, Heenan M, Connolly L, Larkin A, Clynes M.
    Anticancer Res; 2004 Jan; 24(2A):457-64. PubMed ID: 15152944
    [Abstract] [Full Text] [Related]

  • 5. Cyclooxygenase-2 expression influences the growth of human large and small cell lung carcinoma lines in athymic mice: impact of an organoselenium compound on growth regulation.
    El-Bayoumy K, Rose DP, Papanikolaou N, Leszczynska J, Swamy MV, Rao CV.
    Int J Oncol; 2002 Mar; 20(3):557-61. PubMed ID: 11836568
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo.
    Dorai T, Cao YC, Dorai B, Buttyan R, Katz AE.
    Prostate; 2001 Jun 01; 47(4):293-303. PubMed ID: 11398177
    [Abstract] [Full Text] [Related]

  • 7. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
    Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, Price JE.
    Clin Cancer Res; 2005 Oct 15; 11(20):7490-8. PubMed ID: 16243823
    [Abstract] [Full Text] [Related]

  • 8. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ, Kong MJ, Ma ZY, Qian JF, Fan JQ, Xu XH.
    Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1506-9. PubMed ID: 17785094
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model.
    Kang HJ, Lee SH, Price JE, Kim LS.
    Breast J; 2009 Jun 05; 15(3):223-9. PubMed ID: 19645775
    [Abstract] [Full Text] [Related]

  • 11. Determination of minimum effective dose and optimal dosing schedule for liposomal curcumin in a xenograft human pancreatic cancer model.
    Mach CM, Mathew L, Mosley SA, Kurzrock R, Smith JA.
    Anticancer Res; 2009 Jun 05; 29(6):1895-9. PubMed ID: 19528445
    [Abstract] [Full Text] [Related]

  • 12. Antitumor activity of a novel recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand.
    Fang F, Wang AP, Yang SF.
    Acta Pharmacol Sin; 2005 Nov 05; 26(11):1373-81. PubMed ID: 16225761
    [Abstract] [Full Text] [Related]

  • 13. Epidermal growth factor receptor monoclonal antibodies inhibit the growth of lung cancer cell lines.
    Lee M, Draoui M, Zia F, Gazdar A, Oie H, Bepler G, Bellot F, Tarr C, Kris R, Moody TW.
    J Natl Cancer Inst Monogr; 1992 Nov 05; (13):117-23. PubMed ID: 1327029
    [Abstract] [Full Text] [Related]

  • 14. Tanshinone IIA inhibits human hepatocellular carcinoma J5 cell growth by increasing Bax and caspase 3 and decreasing CD31 expression in vivo.
    Chien SY, Kuo SJ, Chen YL, Chen DR, Cheng CY, Su CC.
    Mol Med Rep; 2012 Jan 05; 5(1):282-6. PubMed ID: 22002472
    [Abstract] [Full Text] [Related]

  • 15. Multifunctional role of VIP in prostate cancer progression in a xenograft model: suppression by curcumin and COX-2 inhibitor NS-398.
    Fernández-Martínez AB, Bajo AM, Valdehita A, Isabel Arenas M, Sánchez-Chapado M, Carmena MJ, Prieto JC.
    Peptides; 2009 Dec 05; 30(12):2357-64. PubMed ID: 19772879
    [Abstract] [Full Text] [Related]

  • 16. [Therapeutic effects of recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand on non-small lung cell cancer: an experimental with rats].
    Tang YM, Yang SF, Zhu B, Cui JS.
    Zhonghua Yi Xue Za Zhi; 2005 Aug 03; 85(29):2021-5. PubMed ID: 16313792
    [Abstract] [Full Text] [Related]

  • 17. [An experimental study on the antitumor effects induced by fusions of dendritic cells with NCI-H460 lung cancer cells].
    Zhang ZY, Wu JM, Pan HM.
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Mar 03; 29(3):152-5. PubMed ID: 16677473
    [Abstract] [Full Text] [Related]

  • 18. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.
    Yang L, Mashima T, Sato S, Mochizuki M, Sakamoto H, Yamori T, Oh-Hara T, Tsuruo T.
    Cancer Res; 2003 Feb 15; 63(4):831-7. PubMed ID: 12591734
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U, Lynch J, Sato Y, Kashimoto S, Kajikawa F, Furutani Y, Silverman JA.
    Cancer Chemother Pharmacol; 2009 Jun 15; 64(1):53-65. PubMed ID: 18931998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.